ArticlePloS one2026
Age and tumor size as independent predictors of malignancy in BI-RADS 4 and 5 breast lesions: A cross-sectional study in Vietnam.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate diagnosis of suspicious breast lesions (BI-RADS 4/5) is crucial for appropriate clinical management. The International Academy of Cytology (IAC) Yokohama System standardizes fine-needle aspiration (FNA) cytology reporting, but its performance and the role of independent clinical predictors within this specific high-risk cohort require further investigation. This study aimed to evaluate the diagnostic performance of FNA using the Yokohama system and to identify independent predictors of malignancy in patients with BI-RADS 4 and 5 lesions. METHODS AND
findingsWe conducted a cross-sectional study of 104 female patients with BI-RADS 4/5 breast lesions at two tertiary hospitals in Vietnam. All patients underwent ultrasound-guided FNA with subsequent histopathological examination as the gold standard. Diagnostic performance metrics were calculated. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of malignancy. Of the 104 lesions, 53 (51.0%) were confirmed to be malignant. FNA cytology, interpreted with the Yokohama System, demonstrated a sensitivity of 92.5%, specificity of 96.1%, and an overall accuracy of 94.2%. In the multivariate analysis, only two factors emerged as strong, independent predictors of malignancy: older age (adjusted odds ratio [aOR] 1.13 per year, 95% CI: 1.07-1.19; p < 0.001) and larger tumor size (aOR 1.10 per mm, 95% CI: 1.04-1.16; p = 0.001). Notably, the predictive value of a BI-RADS 5 classification was not statistically significant after this adjustment (p = 0.540). However, given the small BI-RADS 5 subgroup (n = 11), this non-significant result should not be interpreted as evidence of its lack of clinical utility, as the analysis was likely underpowered for this specific variable.
conclusionFNA cytology, when interpreted using the IAC Yokohama System, is a highly accurate and reliable tool for the initial evaluation of BI-RADS 4 and 5 breast lesions. Importantly, our findings demonstrate that older age and larger tumor size are strong, independent predictors of malignancy in this high-risk cohort, highlighting the need to integrate these clinical parameters to optimize risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.